{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:15:26Z","timestamp":1789704926005,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1996,11,1]],"date-time":"1996-11-01T00:00:00Z","timestamp":846806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":6975,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1996,11]]},"DOI":"10.1038\/ki.1996.480","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T12:54:01Z","timestamp":1179406441000},"page":"1641-1650","source":"Crossref","is-referenced-by-count":301,"title":["Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy"],"prefix":"10.1016","volume":"50","author":[{"given":"George L.","family":"Bakris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brian","family":"Copley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Vicknair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Leurgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1996.480_bb0010","first-page":"1","article-title":"Surveillance for diabetes mellitus: United States, 1980\u20131989","volume":"42","author":"Geiss","year":"1993","journal-title":"MMWR Mortality and Morbidity Weekly Report"},{"issue":"Suppl 7","key":"10.1038\/ki.1996.480_bb0015","first-page":"S187","article-title":"The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy","volume":"8","author":"Parving","year":"1990","journal-title":"J Hypertens"},{"key":"10.1038\/ki.1996.480_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.299.6698.533","article-title":"Effect of captopril on blood pressure and kidney treatment in normotensive insulin dependent diabetics with nephropathy","volume":"299","author":"Parving","year":"1989","journal-title":"Br Med J"},{"key":"10.1038\/ki.1996.480_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria","volume":"303","author":"Mathiesen","year":"1991","journal-title":"Br Med J"},{"key":"10.1038\/ki.1996.480_bb0030","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme-inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1996.480_bb0035","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/ki.1994.469","article-title":"Remission of nephrotic range proteinuria in type I diabetes","volume":"46","author":"Hebert","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1996.480_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent diabetes mellitus","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.1996.480_bb0045","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1992.139","article-title":"Treatment of arterial hypertension in diabetic man: Importance of therapeutic selection","volume":"41","author":"Bakris","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1996.480_bb0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/archinte.1993.00410080037006","article-title":"Comparative effects of different antihypertensive treatments on progression of diabetic renal disease","volume":"153","author":"Slataper","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.1996.480_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.300.6729.904","article-title":"Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy","volume":"300","author":"Bjorck","year":"1990","journal-title":"Br Med J"},{"key":"10.1038\/ki.1996.480_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00041552-199605000-00006","article-title":"Microalbuminuria: Prognostic implications","volume":"5","author":"Bakris","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.1996.480_bb0065","series-title":"Calcium Antagonists in Clinical Medicine","first-page":"367","article-title":"Calcium abnormalities and the diabetic, hypertensive patient: Implications of renal preservation","author":"Bakris","year":"1992"},{"key":"10.1038\/ki.1996.480_bb0070","series-title":"Endocrinology of the Vasculature","first-page":"341","article-title":"Analogy bewteen endothelial\/mesangial cell and endothelial\/vascular smooth muscle cell interactions:role of growth factors and mechano-transduction","author":"Bakris","year":"1996"},{"issue":"Suppl I","key":"10.1038\/ki.1996.480_bb0075","first-page":"176","article-title":"Inhibition of human mesangial cell proliferation by calcium channel blockers","volume":"15","author":"Schultz","year":"1990","journal-title":"Hypertension"},{"key":"10.1038\/ki.1996.480_bb0080","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archinte.1995.00430100105012","article-title":"Effect of antihypertensive agents on the kidney","volume":"155","author":"Maki","year":"1995","journal-title":"Arch Intern Med"},{"issue":"Suppl 9","key":"10.1038\/ki.1996.480_bb0085","first-page":"39","article-title":"Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis","volume":"10","author":"Weidmann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1996.480_bb0090","unstructured":"Smith AC, Bakris GL: Differential effects of calcium channel blockers on albuminuria and glomerutar permeability in NIDDM subjects with nephropathy: Pilot results of a two year study. J Am Soc Nephrol (in press)"},{"issue":"Suppl 2","key":"10.1038\/ki.1996.480_bb0095","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1097\/00004872-199508001-00016","article-title":"ACE inhibitors and calcium antagonists alone or combined: Is there a difference on progression of diabetic renal disease","volume":"13","author":"Bakris","year":"1995","journal-title":"J Hypertens"},{"key":"10.1038\/ki.1996.480_bb0100","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1172\/JCI117926","article-title":"Prevention of diabetic nephropathy in db\/db mice with glycated albumin antagonists: A novel treatment stategy","volume":"95","author":"Cohen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1996.480_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1006\/bbrc.1995.1219","article-title":"Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells","volume":"207","author":"Wu","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.1996.480_bb0110","series-title":"SAS\/STAT User's Guide","first-page":"943","year":"1989"},{"key":"10.1038\/ki.1996.480_bb0115","series-title":"Statistical Sciences, S-Plus User's Manual","year":"1993"},{"key":"10.1038\/ki.1996.480_bb0120","first-page":"410","article-title":"Randomized doubly blinded trial of enalapril vs. hydrochlorothiazide on glomerular filtration rate in diabetic nephropathy","volume":"22","author":"Walker","year":"1993","journal-title":"Hypertension"},{"key":"10.1038\/ki.1996.480_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","article-title":"Renal protective effect of enalapril in diabetic nephropathy","volume":"304","author":"Bjorck","year":"1994","journal-title":"Br Med J"},{"issue":"Suppl 45","key":"10.1038\/ki.1996.480_bb0130","first-page":"S150","article-title":"Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria","volume":"45","author":"Lebovitz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1996.480_bb0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15 years end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertens"},{"key":"10.1038\/ki.1996.480_bb0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1996.480_bb0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1038\/ki.1996.480_bb0150","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/00004872-199003001-00009","article-title":"Pathophysiology of proteinuria in diabetic glomerular disease","volume":"8","author":"Myers","year":"1990","journal-title":"J Hypertens"},{"key":"10.1038\/ki.1996.480_bb0155","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jama.1994.03520080042041","article-title":"Effect of glycemic control on early diabetic renal lesions. A 5-year randomised controlled trial of insulin dependent diabetic kidney transplant recipients","volume":"272","author":"Barbosa","year":"1994","journal-title":"JAMA"},{"key":"10.1038\/ki.1996.480_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9343(83)90442-4","article-title":"Nondiabetic renal disease in patients with diabetes mellitus","volume":"75","author":"Kasinath","year":"1983","journal-title":"AM J Med"},{"key":"10.1038\/ki.1996.480_bb0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000188019","article-title":"Nondiabetic renal disease in noninsulin dependent diabetics in a south Indian hospital","volume":"67","author":"John","year":"1994","journal-title":"Nephron"},{"key":"10.1038\/ki.1996.480_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00041552-199403000-00003","article-title":"Renal involvement in type II diabetes","volume":"3","author":"Ritz","year":"1994","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.1996.480_bb0175","first-page":"245","article-title":"On the determinats of the creatinine clearance: A population study","volume":"10","author":"Kesteloot","year":"1996","journal-title":"J Hum Hypertens"},{"key":"10.1038\/ki.1996.480_bb0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0272-6386(12)81023-7","volume":"16","author":"Lemann","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1996.480_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.V74556","article-title":"Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentrations in the modification of diet in renal disease study","volume":"7","author":"Modification of Diet in renal Disease Study Group","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1038\/ki.1996.480_bb0190","first-page":"S101","article-title":"Long-term adherence to \u201cpreferred\u201d vs. \u201calternative\u201d initial drug monotherapy for hypertension in a tertiary clinic","volume":"7","author":"Elliott","year":"1994","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"10.1038\/ki.1996.480_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003495-199200441-00026","article-title":"Quality of life in the treatment of hypertension. The effect of calcium antagonists","volume":"44","author":"Fletcher","year":"1992","journal-title":"Drugs"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815597743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815597743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T23:52:49Z","timestamp":1635551569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815597743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1996,11]]}},"alternative-id":["S0085253815597743"],"URL":"https:\/\/doi.org\/10.1038\/ki.1996.480","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1996,11]]}}}